Literature DB >> 4723259

Dose-dependent enzyme induction.

A Breckenridge, M L Orme, L Davies, S S Thorgeirsson, D S Davies.   

Abstract

Mesh:

Substances:

Year:  1973        PMID: 4723259     DOI: 10.1002/cpt1973144part1514

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  28 in total

1.  Interactions with warfarin.

Authors:  A Breckenridge
Journal:  Br J Clin Pharmacol       Date:  1974-08       Impact factor: 4.335

Review 2.  Interindividual differences in the response to oral anticoagulants.

Authors:  A M Breckenridge
Journal:  Drugs       Date:  1977-11       Impact factor: 9.546

3.  Interaction between doxycycline and some antiepileptic drugs.

Authors:  O Penttilå; P J Neuvonen; K Aho; R Lehtovaara
Journal:  Br Med J       Date:  1974-06-01

4.  Decreased plasma concentrations and clinical effects of alprenolol during combined treatment with pentobarbitone in hypertension.

Authors:  P Seideman; K O Borg; K Haglund; C Von Bahr
Journal:  Br J Clin Pharmacol       Date:  1987-03       Impact factor: 4.335

5.  Clinical evaluation of prolonged chemotherapy combined with induction of hepatic drug-metabolizing enzymes as an adjuvant for treating patients with gastric cancer.

Authors:  S Fujimoto; M Miyazaki; Y Kitsukawa; K Okui; T Hosaka; S Karaki; S Kawanomoto
Journal:  Jpn J Surg       Date:  1983-11

6.  A study of the relationship between the pharmacokinetics and the pharmacodynamics of the 4-hydroxycoumarin anticoagulants warfarin, difenacoum and brodifacoum in the rabbit.

Authors:  A M Breckenridge; S Cholerton; J A Hart; B K Park; A K Scott
Journal:  Br J Pharmacol       Date:  1985-01       Impact factor: 8.739

7.  A comparative study of the relative enzyme inducing properties of anticonvulsant drugs in epileptic patients.

Authors:  E Perucca; A Hedges; K A Makki; M Ruprah; J F Wilson; A Richens
Journal:  Br J Clin Pharmacol       Date:  1984-09       Impact factor: 4.335

Review 8.  Drug interactions and clinical pharmacokinetics.

Authors:  M B Kristensen
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

9.  Hepatic enzyme induction and leucocyte delta-aminolaevulinic acid synthase activity: studies with carbamazepine.

Authors:  W G Rapeport; G T McInnes; G G Thompson; G Forrest; B K Park; M J Brodie
Journal:  Br J Clin Pharmacol       Date:  1983-08       Impact factor: 4.335

10.  Saliva carbamazepine levels in children before and during multiple dosing.

Authors:  T A Moreland; D A Priestman; G W Rylance
Journal:  Br J Clin Pharmacol       Date:  1982-05       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.